Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Jun 2023 for Prometheus Biosciences, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Martin Hendrix: trading record in brief
Martin Hendrix discloses dealings in Prometheus Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 19 May 2023 to 16 June 2023, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 16 June 2023, reports a transaction in Prometheus Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Martin Hendrix
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,071 sharesCommon StockSEC:0000899243-23-015762:0
2,071 shares0Common StockSEC:0001209191-23-031180:0
2 of 2 declarations
